Stockreport

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

XTL Biopharmaceuticals Ltd. - American Depositary Shares  (XTLB) 
US:NASDAQ Investor Relations: xtlbio.com
PDF RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has re [Read more]